A San Diego attorney expects the decision by the National Institutes of Health and the Office of Government Ethics to ban all NIH staff scientists from accepting consulting fees or other income from drug companies will cause an exodus of higher-level scientists and be detrimental to biotechnology companies...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99